×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACLX – arcellx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
05:57 am
aclx
ASH 2024: Arcellx publishes positive results for Anito-cel in multiple myeloma [Yahoo! Finance]
Low
Report
ASH 2024: Arcellx publishes positive results for Anito-cel in multiple myeloma [Yahoo! Finance]
12/10
01:30 pm
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at UBS Group AG from $106.00 to $114.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at UBS Group AG from $106.00 to $114.00. They now have a "buy" rating on the stock.
12/10
08:00 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $115.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $115.00 price target on the stock.
12/9
08:11 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $105.00 price target on the stock.
Medium
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $105.00 price target on the stock.
12/8
11:02 pm
aclx
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition [Yahoo! Finance]
Low
Report
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition [Yahoo! Finance]
12/8
11:00 pm
aclx
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
Low
Report
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
12/5
07:55 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
11/13
01:26 pm
aclx
Are You Looking for a Top Momentum Pick? Why Arcellx, Inc. (ACLX) is a Great Choice [Yahoo! Finance]
Medium
Report
Are You Looking for a Top Momentum Pick? Why Arcellx, Inc. (ACLX) is a Great Choice [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/12
06:01 am
aclx
Form 8-K Arcellx, Inc. For: Dec 09
Medium
Report
Form 8-K Arcellx, Inc. For: Dec 09
12/9
06:11 am
aclx
Form 8-K Arcellx, Inc. For: Dec 08
Medium
Report
Form 8-K Arcellx, Inc. For: Dec 08
12/5
05:58 pm
aclx
Form 4 Arcellx, Inc. For: Dec 03 Filed by: Patel Kavita
Low
Report
Form 4 Arcellx, Inc. For: Dec 03 Filed by: Patel Kavita
11/22
04:12 pm
aclx
Form SC 13G Arcellx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SC 13G Arcellx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
11/19
06:47 pm
aclx
Form 4 Arcellx, Inc. For: Nov 15 Filed by: Gilson Michelle
Low
Report
Form 4 Arcellx, Inc. For: Nov 15 Filed by: Gilson Michelle
11/14
04:37 pm
aclx
Form 4 Arcellx, Inc. For: Nov 12 Filed by: Patel Kavita
High
Report
Form 4 Arcellx, Inc. For: Nov 12 Filed by: Patel Kavita
11/14
04:36 pm
aclx
Form SC 13G/A Arcellx, Inc. Filed by: Paradigm Biocapital Advisors LP
High
Report
Form SC 13G/A Arcellx, Inc. Filed by: Paradigm Biocapital Advisors LP
11/14
04:32 pm
aclx
Form SC 13G/A Arcellx, Inc. Filed by: PERCEPTIVE ADVISORS LLC
High
Report
Form SC 13G/A Arcellx, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: